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Profound type I interferon (IFN-I)-dependent attrition of memory CD8 and CD4 T cells occurs early
during many infections. It is dramatic at 2 to 4 days following lymphocytic choriomeningitis virus (LCMV)
infection of mice and can be elicited by the IFN-inducing Toll receptor agonist poly(I:C). We show that this
attrition occurs in many organs, indicating that it is due to T cell loss rather than redistribution. This loss
correlated with elevated intracellular staining of T cells ex vivo for activated caspases but with only low
levels of ex vivo staining with annexin V, probably due to the rapid clearance of apoptotic cells in vivo.
Instead, a high frequency of annexin V-reactive CD8 dendritic cells (DCs), which are known to be highly
phagocytic, accumulated in the spleen as the memory T cell populations disappeared. After short in vitro
incubation, memory phenotype T cells isolated from LCMV-infected mice (day 3) or mice treated with
poly(I:C) (12 h) displayed substantial DNA fragmentation, as detected by terminal deoxynucleotidyltrans-
ferase-mediated dUTP-biotin nick end labeling (TUNEL) assay, compared to T cells isolated from unin-
fected mice, indicating a role for apoptosis in the memory T cell attrition. This apoptosis of memory CD8
T cells early during LCMV infection was reduced in mice lacking the proapoptotic molecule Bim. Evidence
is presented showing that high levels of T cell attrition, as found in young mice, correlate with reduced
immunodomination by cross-reactive memory cells.
A pronounced type I interferon (IFN-I)-dependent, body-
wide attrition of “memory phenotype” (CD44high) CD8 T
cells occurs in mice during the early stages of viral infections or
after exposure to IFN-I-inducing toll-like receptor (TLR) ago-
nists, such as poly(I:C) (3, 27). This attrition can also be in-
duced by injection of mice with IFN-I and is not seen in
virus-infected or TLR agonist-treated mice lacking IFN-I re-
ceptors (27). Severe attrition of T cells can be seen in other
animal models (31, 35), and a severe lymphopenia is a common
pathological characteristic of human infections with many vi-
ruses, including measles virus, influenza virus, Ebola virus,
Lassa fever virus, lymphocytic choriomeningitis virus (LCMV),
West Nile virus, and severe acute respiratory syndrome
(SARS) virus (3, 4, 13, 14, 27, 30, 33, 45). The disappearance
of memory T cells from the blood can be due to other factors,
such as the IFN-I-driven sequestration of T cells in lymph
nodes, so in many of the human studies there has not been a
body-wide analysis of T cell loss. Here we are referring to a
global attrition throughout the body in these mouse studies.
The mechanisms behind this global T cell attrition in mice
remain poorly understood and could be associated with differ-
ent pathways, including direct killing of T cells by a virus
(unlikely with LCMV), migration of T cells to sites inaccessible
for analysis, or cytokine-driven apoptosis of memory T cells.
IFN-I dependence of memory cell loss was originally shown in
mice at 2 to 4 days after LCMV infection (27). This early
attrition was characterized by losses in many types of leuko-
cytes, but bona fide antigen-specific memory cells and memory
phenotype CD8 CD44high T cells were among the most sus-
ceptible. This loss in memory CD8 T cells has also been shown
with the TLR agonist and potent IFN-I inducer poly(I:C), and
this attrition has been thought to be due to apoptosis, since
CD8 CD44high cells stain positively with active caspase sub-
strates and with the early apoptosis marker annexin V (3, 21,
27). Our continued analyses of these systems showed a similar
attrition of CD44high CD4 T cells, but this population did not
costain highly with annexin V directly ex vivo. This led us to
question if the losses of CD8 CD44high and CD4 CD44high
T cells were occurring by different mechanisms.
Here we show that the increased annexin V CD8
CD44high population consisted mostly of highly phagocytic
lymphoid-like CD8 dendritic cells (DCs) instead of T cells.
At these early stages after poly(I:C) induction or viral in-
fection, the number of CD8 DCs increases substantially,
and the phagocytic clearance system appears to be so effi-
cient that most bona fide dying T cells are likely cleared
before they can be stained for annexin V or DNA fragmen-
tation (terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling [TUNEL]) immediately ex
vivo. This is not true later on in infection, when annexin
V-positive (annexin V) bona fide antigen-specific CD8 T
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cells can easily be detected, as the clearance system for
dying cells seems to be overwhelmed (40, 41).
At early stages of infection, the annexin V-reactive CD8
cells were therefore predominantly DCs and not T cells. This
caused us to undertake a further analysis of the mechanism of
attrition of the CD8 CD44high and CD4 CD44high T cell
populations. We show here that virus- and poly(I:C)-induced
IFN-I-mediated apoptosis of CD8 CD44high and CD4
CD44high T cells does indeed occur, but this requires a short in
vitro incubation to demonstrate the DNA fragmentation. Fur-
thermore, the loss of CD8 CD44high T cells was even greater
than previously thought, due to the contamination with the
CD8 DC population, which bound to annexin V. Further,
we show that the IFN-I-induced apoptosis of these memory T
cells is impaired in mice lacking the proapoptotic protein Bim.
MATERIALS AND METHODS
Virus stocks. LCMV strain Armstrong, an ambisense RNA virus in the Old
World arenavirus family, and Pichinde virus (PV), strain AN3739, a New World
arenavirus only distantly related to LCMV, were propagated in BHK21 baby
hamster kidney cells (42, 46). LCMV and PV were titrated by plaque assay on
Vero cells.
Mice. Male C57BL/6 mice were purchased from The Jackson Laboratory (Bar
Harbor, ME). All mice were purchased at 5 to 6 weeks of age and maintained
under specific-pathogen-free conditions within the Department of Animal Med-
icine at the University of Massachusetts Medical School. C57BL/6-Bim knockout
mice (Bim KO) were originally generated by Andreas Strasser (6) and were
purchased from the Jackson Laboratory. Mice were infected intraperitoneally
(i.p.) with 5  104 PFU of LCMV and were considered immune at 6 weeks or
longer after infection. All experiments were done within institutional guidelines
as approved by the Institutional Animal Care and Use Committee of the Uni-
versity of Massachusetts Medical School.
Lymphocyte preparation for flow cytometric analysis. Spleens and inguinal
lymph nodes (iLN) were isolated from tissue and homogenized using frosted
glass slides. Lungs were isolated from the tissue and cut into small pieces with
razor blades, followed by further homogenization using frosted glass slides. The
resulting cell suspensions from all three organs were depleted of red blood cells
using a 0.84% NH4Cl solution (5 min at 4°C). For the isolation of peritoneal
exudate cells (PECs), the skin was removed while leaving the peritoneal mem-
brane intact. Approximately 6 ml of cold RPMI was injected into the peritoneal
cavity using an 18-gauge needle and then aspirated to collect PECs. Peripheral
blood lymphocytes (PBLs) were isolated via tail vein bleeding, and red blood
cells were depleted using a 0.84% NH4Cl solution (10 min at 37°C). All cell
suspensions were washed in phosphate-buffered saline (PBS) and filtered
through nylon mesh prior to flow cytometry staining.
Apoptosis assays. For some experiments, apoptosis was evaluated via flow
cytometry using fluorescently conjugated annexin V (BD Pharmingen). Upon the
completion of surface staining, the cells were washed and incubated in annexin
V binding buffer with annexin V at a 1:20 dilution for 15 min at room temper-
ature. The cells were then washed, resuspended in annexin V binding buffer, and
analyzed by flow cytometry immediately. Annexin V staining was done in con-
junction with the vital dye 7-amino-actinomycin D (7-AAD) to differentiate early
apoptosis (annexin V 7-AAD) from late apoptosis/necrosis (annexin V
7-AAD).
Apoptosis was also evaluated via flow cytometry using terminal deoxynucleo-
tidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL). Erythrocytes
were removed from harvested splenocytes using a 0.84% NH4Cl solution. Spleen
leukocytes were added to a 48-well plate at 1  106 cells per well and incubated
at either 37°C (5% CO2) or 4°C for 5 h. Cells were then harvested and stained
with the appropriate fluorescent surface antibodies. Upon completion of surface
staining, the cells were fixed according to the manufacturer’s protocol. TUNEL-
positive (TUNEL) cells were detected using an ApoDIRECT in situ DNA
fragmentation assay kit (BioVision).
Synthetic peptides. Previously defined T cell epitopes encoded by LCMV were
used in this study (36, 43). LCMV-specific epitopes include GP33-41 (KAVYN
FATC) and NP205-212 (YTVKYPNL). A previously defined T cell epitope
encoded by PV, NP38-45 (SALDFHKV), was also used in this study (8). All
peptides listed above were purchased from 21st Century Biochemicals and were
purified by reverse-phase high-pressure liquid chromatography (HPLC) to 90%
purity.
Inoculations. Poly(I:C) (Invivogen) was administered at a dose of 200 g in
200 l of Hanks balanced salt solution (HBSS) per mouse i.p. For the induction
of an acute LCMV-Armstrong infection, mice were injected i.p. with 5  104
PFU of virus in 0.1 ml of PBS. For the induction of an acute PV infection, mice
were injected i.p. with 2  107 PFU of virus in 0.1 ml of PBS.
Intracellular IFN- staining. LCMV-specific memory CD8 T cells were de-
tected by measuring intracellular IFN- production in response to stimulation
with LCMV peptides using the Cytofix/Cytoperm Kit Plus (with GolgiPlug; BD
Pharmingen), as described previously (38). Spleen leukocytes (2  106) were
incubated in 96-well plates (5 h; 37°C) with 1 M synthetic peptide, 10 U/ml
human recombinant interleukin-2 (rIL-2) (BD Pharmingen) and 0.2 l of
GolgiPlug (BD Pharmingen). Cells were then washed in flow cytometry buffer
(HBBS, 2% fetal calf serum [FCS], and 0.1% NaN3), blocked with anti-Fc
(2.4G2), and incubated (30 min; 4°C) with the appropriate fluorescent surface
antibodies (BD Pharmingen and eBioscience). Subsequent fixation and perme-
abilization of the cells were performed to allow intracellular access of monoclo-
nal antibody (MAb) to IFN- and tumor necrosis factor (TNF) (eBioscience).
Freshly stained samples were analyzed on a BD Biosciences LSR II with FlowJo
software.
Statistical analyses. Student’s t test and linear correlation were calculated
using GraphPad InStat and used for data analysis where appropriate. Results are
expressed as the mean  standard deviation.
RESULTS
Poly(I:C)-induced attrition of T cells does not correlate with
an increase in annexin V reactivity on T cells. We initially
reevaluated the attrition of CD8 and CD4 T cells in mice
stimulated with the type I IFN inducer poly(I:C). Figure 1
shows that poly(I:C) treatment of C57BL/6 mice resulted in a
52% decrease in the percentage of CD8 CD44high cells
relative to the untreated control (Fig. 1A) and a corresponding
2.5-fold increase in the percentage of annexin V reactivity at
12 h postinoculation (Fig. 1B). CD4 CD44high cells under-
went a similar loss in percentage (58%) (Fig. 1A) but, surpris-
ingly, did not have a substantial increase in annexin V reactivity
after poly(I:C) inoculation (Fig. 1B). We questioned why the
annexin V staining of these two disappearing populations dif-
fered, so we utilized a MAb to the CD8 chain to further
define the CD8 cell population. There was a higher (71%)
decrease in the percentage of CD8 CD44high cells than of
CD8 CD44high cells following poly(I:C) treatment (Fig. 1A),
but this population, like the CD4 cells, had no corresponding
increase in annexin V reactivity (Fig. 1B). No increase in an-
nexin V reactivity was observed in any of the three CD44low
populations following poly(I:C) treatment (data not shown).
These data suggested that there was an increased popu-
lation of annexin V-reactive cells expressing a CD8 ho-
modimer (CD8) and lacking CD8, so we further char-
acterized this population of CD8 cells. An apoptosis
RT2 Profiler PCR array revealed an 11-fold increase in
CD40 RNA isolated from CD8 CD44high cells at 6 h after
poly(I:C) relative to an untreated control (data not shown).
Typically, CD40 surface protein expression is thought to be
limited to B cells, DCs, and macrophages (5), although CD8
T cells, under certain conditions, may transiently express
CD40 (7). There was a substantial increase in CD40 protein
on the surface of the CD8 CD44high population at 12 h
after poly(I:C) treatment, relative to the untreated control
(Fig. 1C), and this increase in CD40 expression directly
correlated with an increase in annexin V reactivity (Fig. 1D).
In contrast, CD40 surface protein expression was low on the
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CD8 CD44high population following poly(I:C) treatment
(3%) (Fig. 1C). Since CD40 expression directly correlated
with an increase in annexin V reactivity, we questioned
whether CD40 expression was necessary for the poly(I:C)-
induced attrition. Both wild-type and CD40 KO mice, how-
ever, showed a similar decrease in CD8 CD44high cells
along with a similar corresponding increase in annexin V
reactivity following poly(I:C) treatment (data not shown).
FIG. 1. An increase in CD8 DCs accounts for the observed increase in annexin V-reactive CD8 CD44high cells following poly(I:C)
treatment. C57BL/6 mice were inoculated with poly(I:C) i.p. Splenocytes were harvested at 0 h (untreated) and 12 h postinoculation. (A) Per-
centages of untreated and poly(I:C)-treated CD8 CD44high/low, CD8 CD44high/low, and CD4 CD44high/low cells. (B) Percentages of untreated
and poly(I:C)-treated annexin V CD8 CD44high, annexin V CD8 CD44high, and annexin V CD4 CD44high cells. (C) CD40 expression
on untreated or poly(I:C)-treated CD8 CD44high and CD8 CD44high cells. (D) Annexin V and CD40 expression on untreated or poly(I:C)-
treated CD8 CD44high cells. (E) Thy1.2, CD3, CD11c, and class II (I-AB) expression on untreated or poly(I:C)-treated CD40 CD8 CD44high
(dashed lines) and CD40 CD8 CD44high (gray fill) cells. Gates were set upon 7-AAD cells to exclude dead/necrotic cells. The data are
representative of three independent experiments with three mice per group.
.
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This suggested that the poly(I:C)-induced attrition of
CD8 CD44high cells was not dependent on the expression
of CD40.
We next used a MAb to the pan T cell marker Thy 1.2 to
further characterize these cell populations. While the CD40
CD8 CD44high population expressed Thy1.2, the CD40
CD8 CD44high population did not (Fig. 1E), indicating that
this population did not consist of T cells. This was further
confirmed using a MAb to T cell receptor-associated CD3 (Fig.
1E). We then questioned whether this population of CD40
CD8 CD44high cells was a subset of DCs, since certain DC
populations can express CD8 (29, 39). This cell population
strongly expressed both CD11c and major histocompatibility
complex (MHC) class II, consistent with a DC phenotype (Fig.
1E), and failed to stain with the B cell marker B220 (data not
shown). Collectively, these results show that this population
displays a “lymphoid” DC phenotype that greatly accumulates
in the spleen rapidly after poly(I:C) treatment.
Kinetic analysis of the poly(I:C)-induced increase in CD8
DCs revealed a 2-fold increase in the percentage of CD8
DCs in the spleen as early as 9 h and a 3-fold increase by 12 h
after poly(I:C) treatment, relative to the untreated control
(Fig. 2A). This increase in percentage corresponded to a 2-fold
increase in total CD8 DC number at 9 and 12 h after
poly(I:C) treatment (Fig. 2B). This poly(I:C)-induced increase
in splenic CD8 DC number coupled with the decrease in
CD8 CD44high T cell number was such that the CD8 DC
population became a substantial fraction of the CD8
CD44high cells. This means that the poly(I:C)-induced loss of
CD8 CD44high T cells had actually been underestimated.
Furthermore, the observed increase in annexin V cells was
due to reactivity with the increasing CD8 DC population
rather than the reduced T cell population. The fact that this
early T cell attrition did not correlate with an increase in T cell
annexin V reactivity left it unclear as to whether the T cell
attrition was indeed due to apoptosis.
The attrition of T cells correlates with an increase in DNA
fragmentation. In light of these findings, it was necessary to
reevaluate the early attrition of CD8 T cells using an anti-
CD8 antibody, which is a more exclusive marker for CD8 T
cells than an anti-CD8 antibody. We first conducted a kinetic
analysis of the poly(I:C)-induced attrition of CD8 CD44high
T cells in the spleen. This time course study revealed a 27%
decrease in the percentage of CD8 CD44high T cells as early
as 3 h after poly(I:C) treatment and a 51% decline at 12 h,
relative to untreated controls (Fig. 2C). This was reflected in a
statistically significant decrease in CD8 CD44high T cell
number at 12 h after poly(I:C) treatment, relative to the un-
treated control (Fig. 2D). Figure 2B shows the concomitant
increase in splenic CD8 DC number in the same animals.
This reduction in splenic CD8 CD44high T cells could not be
explained by trafficking to other organs, as the PECs, lungs,
iLN, and peripheral blood all exhibited significant, although
varying, decreases in the percentage of CD8 CD44high T
cells at 12 h following poly(I:C) treatment (Fig. 3A). The
attrition of CD4 CD44high T cells also occurred in all organs
tested following poly(I:C) treatment (Fig. 3B). The percent-
ages of CD8 DCs in the PECs, lungs, iLN, and peripheral
blood were substantially lower (	0.1%) than those in the
spleen, and there was no increase observed in these organs
following poly(I:C) treatment (data not shown). These data
support the notion that the IFN-I-induced attrition of T cells
was a “global” phenomenon and could not be explained by
migration out of the spleen, although a small redistribution of
cells cannot be completely ruled out.
We next questioned whether the poly(I:C)-induced loss of T
cells was due to apoptosis and used the TUNEL assay to
measure DNA fragmentation as an unambiguous indicator of
apoptotic cells. As commonly found by us and others, detection
of TUNEL cells in vivo was difficult, as dying cells are rapidly
scavenged by phagocytic cells bearing receptors for phospha-
tidylserine, which is expressed on the surface of apoptotic cells
(37). Therefore, splenocytes isolated from either untreated or
poly(I:C)-treated wild-type mice were incubated at 37°C for 5 h
in vitro. This technique has been shown in other studies to
reveal DNA fragmentation in freshly isolated cells ex vivo (40,
41). As a control, splenocytes were also incubated at 4°C for
5 h. Incubation at this nonphysiological temperature should
inhibit DNA fragmentation, since metabolic processes would
be hindered. After a brief incubation at 37°C, there was an
increase in the percentage of TUNEL CD8 CD44high T
cells following poly(I:C) treatment, relative to the untreated
controls (n 
 3; P 	 0.02) (Fig. 4A). Although the background
levels of TUNEL staining were higher for CD4 CD44high T
cells, they showed a trend similar to that for CD8 CD44high
T cells (n 
 3; P 	 0.01) (Fig. 4B). These results indicate that
at least some of the attrition of both CD8 CD44high and
CD4 CD44high T cell populations, following poly(I:C) treat-
ment, occurs through an apoptotic mechanism.
CD8 DCs may aid in the clearance of apoptotic cells
following poly(I:C) treatment. It has been shown that the “lym-
phoid” CD8 DC population, similar to that shown to in-
crease in our system, is capable of phagocytosing apoptotic
cells (1, 2) and that monocytes that phagocytose apoptotic
bodies from neighboring apoptotic cells become “false posi-
tive” and react with annexin V (25). This suggests that CD8
DCs might also become annexin V upon engulfing apoptotic
lymphocytes. Therefore, we examined whether this CD8
DC population might be involved in the clearance of apoptotic
cells following poly(I:C) treatment. To do this, we adoptively
transferred carboxyfluorescein succinimidyl ester (CFSE)-la-
beled wild-type spleen leukocytes (Ly5.1) into congenic wild-
type hosts (Ly5.2) and harvested splenocytes at multiple time
points following poly(I:C) treatment. The Ly5.2 CD8
CD11c DC population assimilated CFSE at 9 and 12 h after
poly(I:C) treatment, correlating with an increase in their ex-
pression of the activation marker CD40, while the Ly5.2
CD8 CD11c DC population had a relatively lower capacity
for the uptake of CFSE donor cells at similar time points
(Fig. 5A). This increased uptake of CFSE donor cells by host
CD8 CD11c DCs is shown quantitatively in Fig. 5B. Col-
lectively, these results suggest that the CD8 CD11c
CD40 DC population may aid in the rapid clearance of
apoptotic cells following IFN-I-induced attrition and, in turn,
become reactive with annexin V in the process.
Apoptosis of T cells during the early immune response to
LCMV. Having established that the attrition of memory pheno-
type T cells, following poly(I:C) treatment, was due to apop-
tosis of CD4 and CD8 T cells in the wake of an increase in
annexin V CD8 DCs, we examined the attrition and apop-
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tosis of these populations in mice infected with LCMV. Figure
6A shows an increase in annexin V-reactive CD8 DCs in the
spleen early after LCMV infection (days 0 to 2). This popula-
tion declined thereafter (29). This increase in CD8 DCs was
not as dramatic as with poly(I:C), but these DCs, like those
induced by poly(I:C), expressed CD40 (Fig. 6A, quadrant 3,
inset). A slight increase in the percentage of annexin V-reac-
tive CD8 and CD8 T cells was observed at early time points
following LCMV infection (Fig. 6A, quadrant 1), but this in-
crease was very modest. Therefore, we reevaluated the apop-
totic properties of CD44high T cells at the early stages of in-
fection with LCMV using a CD8 MAb, as no DCs were
detected in the CD8 CD44high gate (Fig. 6A). There was a
substantial decrease in CD8 CD44high T cell numbers as
early as day 2 postinfection (Fig. 6B), and this correlated with
an increase in caspase 3 activation detected ex vivo and peaking
at day 3, though again, annexin V staining, which also peaked
on day 3, was relatively low (Fig. 6C). DNA fragmentation, as
visualized by TUNEL after a 5-h incubation in culture, was
substantial and also peaked at day 3 (Fig. 6D). At day 4 postin-
FIG. 2. The poly(I:C)-induced decrease in CD8 CD44high T cells correlates with an increase in CD8 DCs. C57BL/6 mice were inoculated
with poly(I:C) i.p. Splenocytes were harvested at 0 (untreated), 3, 6, 9, and 12 h after poly(I:C) inoculation. (A) Percentage of CD8 DCs at
multiple time points following poly(I:C) treatment. (B) Absolute numbers of CD8 CD11c DCs at multiple time points following poly(I:C)
treatment. *, P	 0.05 relative to untreated mice. Error bars indicate standard deviations. (C) Percentage of CD8
 CD44high/low T cells at multiple
time points following poly(I:C) treatment. (D) Absolute numbers of CD8 CD44high T cells at multiple time points following poly(I:C) treatment.
Gates were set on 7-AAD cells. Absolute numbers were based upon percentages obtained via flow cytometry. *, P 	 0.05 relative to untreated
mice. The data are representative of three independent experiments with three mice per group.
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fection, CD8 CD44high T cell numbers began to recover
(Fig. 6B), correlating with a decrease in caspase 3 activation
(Fig. 6B) and DNA fragmentation (Fig. 6D). It should be
noted that highly defined antigen-specific T cells can easily
be stained ex vivo with annexin V at later stages of an LCMV
infection (days 7 to 12), when the clearance system for
apoptotic cells is likely overwhelmed (40). Nevertheless,
these data show that much of the early loss of memory
phenotype T cells following LCMV infection is due to an
apoptotic mechanism.
Factors associated with the virus-induced apoptosis of
memory T cells. While the loss of CD8 CD44high T cells is
IFN-I dependent, the molecules downstream of IFN-I signal-
ing that may contribute to this loss are currently undefined.
Having established that the LCMV-induced loss of CD8
CD44high T cells was at least partly due to apoptosis, we next
evaluated the mechanisms that may contribute to this loss. Bim
is a proapoptotic molecule involved in mitochondrion-induced
apoptosis, and IFN-I was found to induce apoptosis in certain
myeloma cell lines through the upregulation of Bim (15). Bim
has been shown to play a role in inhibiting the decline in
number of LCMV-specific T cells at the termination of infec-
tion and to influence the specificity of clonal exhaustion during
persistent LCMV infections (16, 44). We questioned whether
the early apoptosis of CD8 CD44high T cells would be re-
FIG. 3. Trafficking to other compartments does not account for the loss of CD8 CD44high and CD4 CD44high T cells from the spleen
following poly(I:C) treatment. C57BL/6 mice were inoculated with poly(I:C) i.p. Splenocytes, peritoneal exudate cells (PECs), lungs, inguinal
lymph nodes (iLN), and peripheral blood lymphocytes (PBLs) were harvested at 0 (untreated) and 12 h postinoculation. (A) Plots display the
percentages of untreated and poly(I:C)-treated CD8 CD44high/low T cells. (B) Plots display the percentages of untreated and poly(I:C)-treated
CD4 CD44high/low T cells. Gates were set upon 7-AAD cells. Each plot is representative of three mice per group, and the percentages displayed
on each plot are the averages for three mice per group. The data are representative of two independent experiments, each with three mice per
group.
.
FIG. 4. The poly(I:C)-induced attrition of CD8 CD44high and
CD4 CD44high T cells correlates with an increase in DNA fragmen-
tation. C57BL/6 mice were inoculated with poly(I:C) i.p. Splenocytes
were harvested at 0 (untreated) and 12 h after poly(I:C) treatment.
DNA fragmentation was assessed via TUNEL staining after a brief in
vitro culture of splenocytes for 5 h at either 37°C or 4°C (see Materials
and Methods). (A) Plots show the percentage of untreated or poly(I:
C)-treated TUNEL CD8 CD44high T cells (37°C and 4°C).
(B) Plots show the percentage of untreated or poly(I:C)-treated
TUNEL CD4 CD44high T cells (37°C and 4°C). Each plot is repre-
sentative of three mice per group, while the percentages displayed on
each plot are the averages for three mice per group. The data are
representative of three independent experiments.
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duced in Bim KO mice relative to wild-type mice at 3 days after
LCMV infection. The cell numbers among individual Bim KO
mice were quite variable, making studies on total cell numbers
difficult to address without using very large numbers of mice
for replicas. Nevertheless, Fig. 7A shows a representative ex-
periment where about 50% of wild-type CD8 CD44high T
cells were depleted in percentage at 3 days after LCMV infec-
tion, compared to fewer than 30% of Bim KO CD8
CD44high cells, relative to their respective untreated controls
(Fig. 7A).
Since the variations in cell numbers among Bim KO mice
were problematic for these analyses, we rationalized that the
degree of apoptosis within individual mice was a more reliable
indicator of whether Bim was influencing LCMV-induced apop-
tosis of CD8 CD44high T cells. Therefore, we tested these
cells in the TUNEL assay after in vitro incubation at 37°C. At
3 days after LCMV infection, the percentage of Bim KO
TUNEL CD8 CD44high T cells was significantly lower than
in the wild type (n 
 3; P 	 0.05) (Fig. 7B). Interestingly,
untreated Bim KO mice had a higher percentage of effector
memory phenotype CD8 T cells (CCR7 CD62L) than wild-
type controls (data not shown), and others have shown that
effector memory phenotype CD8 T cells are less susceptible to
IFN-I-induced attrition than central memory CD8 T cells (20).
Given that the attrition of memory T cells is linked to the
action of type I IFNs, we questioned whether the Bim KO mice
generated normal levels of IFN-I. Sera from wild-type and Bim
KO mice, at 12 h after poly(I:C) treatment or 3 days after
LCMV infection, had similar type I IFN endpoint dilution
FIG. 5. The poly(I:C)-induced increase in CD8 DCs may con-
tribute to the rapid clearance of apoptotic cells. A total of 2  107
CFSE-labeled wild-type splenocytes (Ly5.1) were adoptively trans-
ferred into congenic wild-type recipients (Ly5.2). Splenocytes were
harvested at 0 (untreated), 3, 6, 9, and 12 h after poly(I:C) treatment.
(A) The capacities of Ly5.2 CD8 CD11c and Ly5.2 CD8
CD11c DCs to take up Ly5.1 CFSE cells were correlated with
CD40 expression at indicated the time points Doublets were excluded
via pulse width, and gates were set upon Ly5.2 CD11c 7-AAD
cells. (B) The plot shows the percentages of host (Ly5.2) CD8 and
CD8 CFSE DC populations following poly(I:C) treatment. Each
data point is the average for three mice, and the data are representa-
tive of three independent experiments, each with three mice per data
point. Error bars indicate standard deviations.
.
FIG. 6. The LCMV-induced attrition of CD8 CD44high T cells
correlates with a substantial increase in DNA fragmentation and
caspase 3 activation but not annexin V reactivity. C57BL/6 mice were
infection with LCMV-Armstrong i.p. Splenocytes were harvested at 0,
1, 2, 3, and 4 days postinfection. DNA fragmentation was assessed via
TUNEL staining after a brief in vitro culture of splenocytes for 5 h at
37°C (see Materials and Methods). (A) Annexin V and CD11c staining
on CD8 CD44high and CD8 CD44high cells at days 0,1, and 2 after
LCMV infection. Histogram inset in quadrant 3 show CD40 expression
on the annexin V CD11c CD8 CD44high population (quadrant 2).
(B) Absolute CD8 CD44high T cell numbers at 0, 1, 2, 3, and 4 days
postinfection. Error bars indicate standard deviations. (C) Histogram
overlays depicting CD8 CD44high annexin V reactivity and caspase
3 activation on days 0, 1, 2, 3, and 4 after LCMV infection. Line color
corresponds to day after LCMV infection. (D) Percentages of
TUNEL CD8 CD44high T cells isolated from mice at days 0, 1, 2,
3, and 4 postinfection. Absolute numbers were based upon percentages
obtained via flow cytometry. The data are representative of three
independent experiments with three mice per group.
.
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titers in a standard bioassay using microtiter plate wells of
L-929 cells challenged with vesicular stomatitis virus (1/2,500
dilution of serum). Therefore, differences in apoptosis between
wild-type and Bim KO T cells cannot be attributed to differ-
ences in IFN-I production.
Reduced attrition of cross-reactive memory cells in old
LCMV-immune mice may limit the diversity of the ensuing
immune response to heterologous Pichinde virus infection.
Others have shown that aged mice develop less memory T cell
attrition and mount a weaker CD8 T cell response to LCMV
than do younger mice (19, 23). LCMV and PV encode epitopes
in the nucleoprotein NP205-212 sharing 6 of 8 amino acids. In
a naïve host, NP205 is normally a subdominant epitope for
both viruses, specific for usually 	3% of the CD8 T cells,
However, due to a selective expansion of NP205-specific cross-
reactive memory CD8 T cells, the NP205-specific T cell re-
sponse becomes more dominant when LCMV-immune mice
are infected with PV, demonstrating how cross-reactive expan-
sion of T cells can alter the hierarchy of T cell responses (8).
Using this LCMV/PV cross-reactive model, we questioned
whether the reduced apoptosis of a cross-reactive memory
CD8 population (NP205) in aged LCMV-immune mice would
allow the cross-reactive cells to more vigorously dominate the
immune response following heterologous PV challenge, as we
previously predicted by computer modeling (3). These com-
puter models predicted that attrition of cross-reactive memory
CD8 T cells reduces their immunodominance and allows for a
more diverse immune response, because memory CD8 T cells
are more susceptible to the IFN-I-induced attrition than are
naïve CD8 T cells (3, 27).
We therefore tested the hypothesis that aged mice, which
have less IFN-I-induced attrition than young mice, would
mount a greater cross-reactive response than would young
mice. Young and aged naïve (Fig. 8A) or LCMV-immune (Fig.
8B and C) mice were infected with PV, which, like LCMV,
induces a potent IFN-I response. At day 8 postinfection, the
frequencies of the cross-reactive memory (NP205) and non-
cross-reactive normally immunodominant PV-specific (NP38)
CD8 T cells were determined via intracellular IFN- assay.
Both young and aged naïve controls had comparable PV NP38-
specific responses at day 8 postinfection (18% and 16% of the
CD8 population, respectively) (Fig. 8A); NP205 responses
were 	1% in these mice. Figure 8B shows that at day 8 postin-
fection, a representative LCMV-immune young mouse had an
NP205-to-NP38 ratio of under 1, suggesting that the loss of the
cross-reactive, NP205-specific memory CD8 population al-
lowed for the successful expansion of the newly arising NP38-
specific response. A representative aged LCMV-immune
mouse had an NP205-to-NP38 ratio of over 1, suggesting that
the lack of cross-reactive, NP205-specific memory CD8 cell
attrition allowed this population to dominate, thereby, hinder-
ing the expansion of the newly arising NP38 response (Fig. 8B).
This point is further emphasized in Fig. 8C, where the NP205-
to-NP38 ratios in multiple young and old LCMV-immune mice
were compared at day 8 after PV infection. This revealed
young mice to have a significantly lower ratio than aged mice
(1.5 versus 2.5, respectively) (Fig. 8C) (P 	 0.05). This differ-
ence in ratio could be due to aged LCMV-immune mice having
higher NP205 frequencies prior to PV infection. Therefore, the
potential for the NP205 population to dominate may be de-
pendent upon the initial NP205 frequency prior to infection.
However, there was no correlation between the initial NP205
frequency and its ability to dominate the immune response at
day 8 after PV infection (as indicated by the NP205/NP38
ratio) when data from both young and aged mice were pooled
(r2 
 0.1936; n 
 14) or analyzed separately (young, r2 

0.1850 [n 
 7]; aged, r2 
 0.3280 [n 
 7]). Although there
could be other interpretations, these results are consistent with
the concept that the early virus-induced attrition limits the size
of the cross-reactive memory pool (NP205) and allows for the
successful expansion of non-cross-reactive clones from the
naïve pool.
DISCUSSION
It was previously shown that the IFN-I-induced attrition of
CD8 CD44high cells occurring after viral infection or TLR
agonist treatment correlated with an increase in annexin V
FIG. 7. The LCMV-induced apoptosis of CD8 CD44high T cells
is partially dependent on Bim. C57BL/6 (wild-type) and Bim-deficient
(Bim KO) mice were infected with LCMV-Armstrong i.p. Splenocytes
were harvested at day 0 (untreated) and 3 days postinfection. DNA
fragmentation was assessed via TUNEL staining after a brief in vitro
culture of splenocytes for 5 h at 37°C (see Materials and Methods).
(A) The plots show the percentages of untreated and LCMV-infected
wild-type and Bim KO CD8 CD44high T cells. (B) The plots show
the percentages of untreated and LCMV-infected wild-type and Bim
KO TUNEL CD8 CD44high T cells. Each plot is representative of
three mice per group, while the percentages are the averages for three
mice per group. The data are representative of three independent
experiments.
.
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reactivity, suggesting that this loss occurred through an apop-
totic mechanism (Fig. 1) (3, 27). It was believed that this
CD8 CD44high population consisted primarily of T cells, but
here we show that a population of “lymphoid” CD8 DCs,
within the CD8 CD44high gate, increased substantially upon
poly(I:C) treatment (Fig. 1). This DC population accounted
for the annexin V-reactive cells at 12 h following poly(I:C)
treatment (Fig. 1). This observation made necessary a reeval-
uation of the IFN-I-induced attrition of memory T cells occur-
ring during viral infection or poly(I:C) treatment. Our results
using anti-CD8 antibody, which is a more exclusive stain for
CD8 T cells than an anti-CD8 antibody, indicated that there
was even more CD8 T cell attrition than previously thought
(Fig. 2C and D) and that there also was substantial attrition of
CD4 memory phenotype T cells.
Three potential mechanisms that could account for this loss
were migration away from the organ tested (spleen), increased
adherence to structural tissue, and death. Although inflamma-
tory cytokines can alter the trafficking patterns of T cells, we
observed a similar loss of CD8 CD44high and CD4
CD44high T cells in spleen, PECs, lungs, iLN, and peripheral
blood following poly(I:C) treatment (Fig. 3A and B). A similar
loss was also observed in the bone marrow (data not shown).
Although it is difficult to rule out trafficking into compartments
that we have not yet examined, these data indicate that the loss
of CD8 CD44high and CD4 CD44high T cells is a global
phenomenon affecting many tissues, without an accumulation
of cells at a discrete site of infection. Inflammatory cytokines
can also affect the adherence properties of T cells. Others have
reported a transient decline of antigen-specific memory CD8 T
cells in the spleens of mice early after Listeria monocytogenes
infection. One study suggests that this is due to a generalized
IFN-I-dependent apoptosis (27), and another study concludes
that this was a consequence of the T cells undergoing an
antigen-presenting cell (APC)-dependent conditioning phase
that renders them undetectable by flow cytometry but readily
detectable by histological techniques (18). This phenomenon,
termed T cell conditioning, is a process whereby APCs laden
with antigen form aggregates with antigen-specific T cells,
thereby preventing them from being properly extracted or pro-
FIG. 8. Reduced attrition in aged LCMV-immune mice limits the diversity in the arising T cell response following heterologous Pichinde virus
(PV) challenge. Young (6 to 8 months) and aged (18 to 22 months) LCMV-immune mice were prebled to determine NP205-specific CD8 T cell
frequencies prior to infection with PV, via an intracellular cytokine assay. Mice were rebled on day 8 after PV infection, and the ratios of the NP205
to the NP38 response were determined via intracellular cytokine assay. (A) Frequencies of NP38-specific CD8 T cells, as revealed by intracellular
IFN- assay, in young and aged naïve mice. (B) Frequencies of NP38- and NP205-specific CD8 T cells at day 8 after PV infection, as revealed
by intracellular IFN- assay, in young and old LCMV-immune mice. (C) Ratio of the NP205 to NP38 response for multiple young and old
LCMV-immune mice (day 8 after PV infection). The plots in panels A and B show one representative mouse, while panel C shows the NP205/NP38
frequencies for all mice over multiple experiments.
.
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cessed for analysis by flow cytometry (18, 26). However, the
IFN-I-induced attrition affects all memory cells equally,
whereas conditioning is antigen specific. LCMV infection
causes substantial reductions in the frequencies of CD8 T cells
that are specific to a heterologous virus as early as 2 days
postinfection, and these frequencies do not recover as the
infection resolves, a finding that neither migration nor T cell
conditioning can account for (24). Further, we were unable to
account for the T cell loss by treating tissues with Liberase
(Roche), a purified enzyme blend (data not shown). This sug-
gests that long-term loss in memory is, in large part, a conse-
quence of the IFN-I-dependent apoptotic loss in memory CD8
T cells.
Here we demonstrate substantial levels of apoptosis of mem-
ory phenotype CD8 and CD4 T cells when T cells isolated from
poly(I:C)-treated or LCMV-infected mice are examined by
TUNEL assay after a short in vitro incubation. This apoptosis
could be readily seen only if cells from affected mice were
incubated in vitro for 4 to 5 h, as the in vivo clearance system
for apoptotic cells seems to be quite effective at the time points
studied. Here we also report the first evidence of Bim’s in-
volvement in the early apoptosis of T cells following LCMV
infection. The attrition of CD8 CD44high T cells was re-
duced in Bim KO mice at 3 days after LCMV infection relative
to that in wild-type mice (Fig. 7A). The reduced attrition
corresponded with a decrease in DNA fragmentation, as re-
vealed by TUNEL, in Bim KO CD8 CD44high T cells rela-
tive to wild-type CD8 CD44high T cells (Fig. 7B). Overall,
the reduced attrition coupled with the reduction in DNA frag-
mentation in Bim KO mice suggests that Bim may contribute
to the apoptosis of CD8 CD44high T cells following LCMV
infection, and these results are another argument supporting
the concept that apoptosis is indeed responsible for memory T
cell attrition. Nevertheless, Bim KO mice infected with LCMV
were not completely resistant to the early attrition (Fig. 7A),
suggesting that additional mechanisms might be involved.
Type I IFN has been shown to cause the attrition of certain
myeloma cell lines through a mitochondrion-induced pathway
involving Bim (11, 32). As mentioned above, serum IFN-I
levels were similar in wild-type and Bim KO mice at 3 days
after LCMV infection. Therefore, the reduced attrition in Bim
KO mice infected with LCMV is not due to lower levels of type
I IFN induction.
It is unclear whether IFN-I exerts its effects on T cell attri-
tion directly or indirectly. Recently, we generated IFN-I-R
KO/wild-type bone marrow chimeric mice and found that the
IFN-I-R KO memory phenotype T cell population underwent
less attrition following LCMV-Armstrong infection (day 3) or
poly(I:C) treatment (12 h), relative to the corresponding wild-
type population. These data suggest that IFN-I may exert at
least some of its effects directly, which is consistent with IFN-I
modulating Bim expression levels. We document a type I IFN-
dependent increase in CD8 DCs that was greater following
poly(I:C) treatment (Fig. 1 and 2) than after LCMV infection
(Fig. 6A). This is not surprising since CD8 DCs can also be
activated through TLR3, a receptor for poly(I:C) (34). Inter-
estingly, this increase in CD8 DCs correlated with the de-
crease in the CD8 CD44high T cells (Fig. 2). CD8 DCs
might aid in the rapid clearance of apoptotic cells following
poly(I:C) treatment in vivo, as there was an increase in the
uptake of CFSE from labeled congenic donor cells by host
CD8 DCs, following poly(I:C) treatment (Fig. 5). Others
have shown that the engulfment of apoptotic cells results in an
increase in class II expression, a result consistent with our
finding of increased class II expression at 12 h after poly(I:C)
treatment (Fig. 1E) (12). T cells and DCs are in close contact
during antigen presentation, but this would not explain the
increased uptake of CFSE from labeled donor cells by host
DCs, since doublets were gated out using pulse width prior to
analysis.
Monocytes have been shown to phagocytose apoptotic bod-
ies that are shed from the neighboring apoptotic cell and, in
the process, can become “false positive” by the annexin V assay
(25). This suggests that CD8 DCs might become annexin
V upon engulfing apoptotic lymphocytes. The apoptotic phe-
notype, as indicated by an increase in annexin V reactivity,
suggests that the plasma membrane of the CD8 DC might
fuse with the plasma membrane of the apoptotic body it en-
gulfs. Phagocytic cells expressing T cell immunoglobulin- and
mucin-domain-containing molecule (Tim4) have been shown
to associate with exosomes carrying exposed phosphatidylser-
ine, which may also account for the observed increase in an-
nexin V reactivity (28). Nevertheless, the increased annexin V
reactivity also suggests that the DCs could actually be dying.
The typical life span of mature DCs is estimated to be 3 days
in vivo (17, 22). Also, DC populations decline in number by day
3 postinfection. It is not known whether this drop in DCs is due
to migration, phenotypic alterations, and/or cell death, but it is
known to be type I IFN dependent (29). It has been shown that
the surface expression of phosphatidylserine on macrophages
is required for phagocytosis of apoptotic lymphocytes. Pre-
treating these macrophages with annexin V was found to in-
hibit phagocytosis of apoptotic thymocytes (9). Interestingly,
our apoptosis PCR array analysis revealed an increase in IL-10
RNA in the CD8 CD44high population, containing CD8
DCs, at 6 h after poly(I:C) treatment. Exposure of DCs to
IL-10 can suppress the induction of antiapoptotic genes, coin-
ciding with the spontaneous apoptosis of the DC (10).
Our computer modeling predicted that if cross-reactive an-
tigen prevents the type I IFN-induced deletion of a memory T
cell population, those cross-reactive memory T cells would
compete against a more diverse and higher-affinity new T cell
response to the newly encountered pathogen (3). Creating a
biological model to study the consequence of the lack of type
I IFN-induced attrition of memory CD8 T cells during the
early immune response had proven problematic, in part, be-
cause it is difficult to separate the T cell apoptosis-inducing
properties of IFN-I from the myriad of other IFN-I-induced
events that regulate antigen presentation and the subsequent
immune response. Nevertheless, we took advantage of the
finding that aged mice develop less attrition than younger mice
(19, 20) and questioned whether the reduced apoptosis of the
cross-reactive memory CD8 population (NP205) in aged
LCMV-immune mice, following heterologous virus (PV) chal-
lenge, would allow them to dominate the immune response.
We show in Fig. 8 that the cross-reactive memory CD8 T cell
response (NP205) was more immunodominating in aged
LCMV-immune mice than in younger LCMV-immune mice at
day 8 after PV challenge (Fig. 8B and C). The diminished PV
response in aged LCMV-immune mice relative to younger
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LCMV-immune mice could be attributed to aged mice having
a smaller immunologically naïve repertoire, but both young
and old naïve mice mounted similar PV-specific responses at
day 8 postinfection (Fig. 8A). These results may indicate that
the impact of heterologous immunity, whether it be beneficial
or detrimental, may be more profound in older individuals due
to the enhanced responses of cross-reactive T cells.
ACKNOWLEDGMENTS
This work was supported by U.S. National Institutes of Health
research grants AI017672, AI081675, AI073871, AI46692, AI054455,
CA65861, NS054948, and DK080665. R.J.D. is an investigator of the
Howard Hughes Medical Institute.
The opinions expressed are those of the authors and not necessarily
those of the NIH.
We thank Varun Kapoor for helpful discussions.
REFERENCES
1. Albert, M. L., S. F. Pearce, L. M. Francisco, B. Sauter, P. Roy, R. L.
Silverstein, and N. Bhardwaj. 1998. Immature dendritic cells phagocytose
apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to
cytotoxic T lymphocytes. J. Exp. Med. 188:1359–1368.
2. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire
antigen from apoptotic cells and induce class I-restricted CTLs. Nature
392:86–89.
3. Bahl, K., S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, L. K.
Selin, and R. M. Welsh. 2006. IFN-induced attrition of CD8 T cells in the
presence or absence of cognate antigen during the early stages of viral
infections. J. Immunol. 176:4284–4295.
4. Baize, S., P. Marianneau, P. Loth, S. Reynard, A. Journeaux, M. Chevallier,
N. Tordo, V. Deubel, and H. Contamin. 2009. Early and strong immune
responses are associated with control of viral replication and recovery in
Lassa virus-infected cynomolgus monkeys. J. Virol. 83:5890–5903.
5. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van
Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and
its ligand. Annu. Rev. Immunol. 12:881–922.
6. Bouillet, P., D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F.
Kontgen, J. M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative
Bim required for certain apoptotic responses, leukocyte homeostasis, and to
preclude autoimmunity. Science 286:1735–1738.
7. Bourgeois, C., B. Rocha, and C. Tanchot. 2002. A role for CD40 expression
on CD8 T cells in the generation of CD8 T cell memory. Science 297:
2060–2063.
8. Brehm, M. A., A. K. Pinto, K. A. Daniels, J. P. Schneck, R. M. Welsh, and
L. K. Selin. 2002. T cell immunodominance and maintenance of memory
regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3:627–
634.
9. Callahan, M. K., P. Williamson, and R. A. Schlegel. 2000. Surface expression
of phosphatidylserine on macrophages is required for phagocytosis of apop-
totic thymocytes. Cell Death Differ. 7:645–653.
10. Chang, W. L., N. Baumgarth, M. K. Eberhardt, C. Y. Lee, C. A. Baron, J. P.
Gregg, and P. A. Barry. 2007. Exposure of myeloid dendritic cells to exog-
enous or endogenous IL-10 during maturation determines their longevity.
J. Immunol. 178:7794–7804.
11. Chen, Q., B. Gong, A. S. Mahmoud-Ahmed, A. Zhou, E. D. Hsi, M. Hussein,
and A. Almasan. 2001. Apo2L/TRAIL and Bcl-2-related proteins regulate
type I interferon-induced apoptosis in multiple myeloma. Blood 98:2183–
2192.
12. Clayton, A. R., R. L. Prue, L. Harper, M. T. Drayson, and C. O. Savage. 2003.
Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits
CD40, CD80, and CD86 expression and reduces allogeneic T cell responses:
relevance to systemic vasculitis. Arthritis Rheum. 48:2362–2374.
13. Cunha, B. A., B. P. McDermott, and S. S. Mohan. 2004. Prognostic impor-
tance of lymphopenia in West Nile encephalitis. Am. J. Med. 117:710–711.
14. Geisbert, T. W., L. E. Hensley, T. R. Gibb, K. E. Steele, N. K. Jaax, and P. B.
Jahrling. 2000. Apoptosis induced in vitro and in vivo during infection by
Ebola and Marburg viruses. Lab. Invest. 80:171–186.
15. Gomez-Benito, M., P. Balsas, X. Carvajal-Vergara, A. Pandiella, A. Anel, I.
Marzo, and J. Naval. 2007. Mechanism of apoptosis induced by IFN-alpha in
human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin.
Cell Signal. 19:844–854.
16. Grayson, J. M., A. E. Weant, B. C. Holbrook, and D. Hildeman. 2006. Role
of Bim in regulating CD8 T-cell responses during chronic viral infection.
J. Virol. 80:8627–8638.
17. Ingulli, E., A. Mondino, A. Khoruts, and M. K. Jenkins. 1997. In vivo
detection of dendritic cell antigen presentation to CD4() T cells. J. Exp.
Med. 185:2133–2141.
18. Jabbari, A., K. L. Legge, and J. T. Harty. 2006. T cell conditioning explains
early disappearance of the memory CD8 T cell response to infection. J. Im-
munol. 177:3012–3018.
19. Jiang, J., F. Anaraki, K. J. Blank, and D. M. Murasko. 2003. T cells from
aged mice are resistant to depletion early during virus infection. J. Immunol.
171:3353–3357.
20. Jiang, J., D. Gross, S. Nogusa, P. Elbaum, and D. M. Murasko. 2005.
Depletion of T cells by type I interferon: differences between young and aged
mice. J. Immunol. 175:1820–1826.
21. Jiang, J., L. L. Lau, and H. Shen. 2003. Selective depletion of nonspecific T
cells during the early stage of immune responses to infection. J. Immunol.
171:4352–4358.
22. Kamath, A. T., J. Pooley, M. A. O’Keeffe, D. Vremec, Y. Zhan, A. M. Lew, A.
D’Amico, L. Wu, D. F. Tough, and K. Shortman. 2000. The development,
maturation, and turnover rate of mouse spleen dendritic cell populations.
J. Immunol. 165:6762–6770.
23. Kapasi, Z. F., K. Murali-Krishna, M. L. McRae, and R. Ahmed. 2002.
Defective generation but normal maintenance of memory T cells in old mice.
Eur. J. Immunol. 32:1567–1573.
24. Kim, S. K., and R. M. Welsh. 2004. Comprehensive early and lasting loss of
memory CD8 T cells and functional memory during acute and persistent
viral infections. J. Immunol. 172:3139–3150.
25. Marguet, D., M. F. Luciani, A. Moynault, P. Williamson, and G. Chimini.
1999. Engulfment of apoptotic cells involves the redistribution of membrane
phosphatidylserine on phagocyte and prey. Nat. Cell Biol. 1:454–456.
26. Maxwell, J. R., R. J. Rossi, S. J. McSorley, and A. T. Vella. 2004. T cell clonal
conditioning: a phase occurring early after antigen presentation but before
clonal expansion is impacted by Toll-like receptor stimulation. J. Immunol.
172:248–259.
27. McNally, J. M., C. C. Zarozinski, M. Y. Lin, M. A. Brehm, H. D. Chen, and
R. M. Welsh. 2001. Attrition of bystander CD8 T cells during virus-induced
T-cell and interferon responses. J. Virol. 75:5965–5976.
28. Miyanishi, M., K. Tada, M. Koike, Y. Uchiyama, T. Kitamura, and S.
Nagata. 2007. Identification of Tim4 as a phosphatidylserine receptor. Na-
ture 450:435–439.
29. Montoya, M., M. J. Edwards, D. M. Reid, and P. Borrow. 2005. Rapid
activation of spleen dendritic cell subsets following lymphocytic choriomen-
ingitis virus infection of mice: analysis of the involvement of type 1 IFN.
J. Immunol. 174:1851–1861.
30. Nabeshima, S., M. Murata, K. Kikuchi, H. Ikematsu, S. Kashiwagi, and J.
Hayashi. 2002. A reduction in the number of peripheral CD28CD8T
cells in the acute phase of influenza. Clin. Exp. Immunol. 128:339–346.
31. Nishimura, Y., T. Igarashi, A. Buckler-White, C. Buckler, H. Imamichi,
R. M. Goeken, W. R. Lee, B. A. Lafont, R. Byrum, H. C. Lane, V. M. Hirsch,
and M. A. Martin. 2007. Loss of naive cells accompanies memory CD4
T-cell depletion during long-term progression to AIDS in simian immuno-
deficiency virus-infected macaques. J. Virol. 81:893–902.
32. Otsuki, T., O. Yamada, H. Sakaguchi, A. Tomokuni, H. Wada, Y. Yawata,
and A. Ueki. 1998. Human myeloma cell apoptosis induced by interferon-
alpha. Br. J. Haematol. 103:518–529.
33. Schneider-Schaulies, S., and J. Schneider-Schaulies. 2009. Measles virus-
induced immunosuppression. Curr. Top. Microbiol. Immunol. 330:243–269.
34. Schulz, O., S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte, L. Alexo-
poulou, Y. T. Azuma, R. A. Flavell, P. Liljestrom, and C. Reis e Sousa. 2005.
Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature
433:887–892.
35. Tompkins, M. B., P. D. Nelson, R. V. English, and C. Novotney. 1991. Early
events in the immunopathogenesis of feline retrovirus infections. J. Am. Vet.
Med. Assoc. 199:1311–1315.
36. van der Most, R. G., K. Murali-Krishna, J. L. Whitton, C. Oseroff, J.
Alexander, S. Southwood, J. Sidney, R. W. Chesnut, A. Sette, and R. Ahmed.
1998. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell
responses in lymphocytic choriomeningitis virus-infected mice. Virology 240:
158–167.
37. van Engeland, M., L. J. Nieland, F. C. Ramaekers, B. Schutte, and C. P.
Reutelingsperger. 1998. Annexin V-affinity assay: a review on an apoptosis
detection system based on phosphatidylserine exposure. Cytometry 31:1–9.
38. Varga, S. M., and R. M. Welsh. 1998. Detection of a high frequency of
virus-specific CD4 T cells during acute infection with lymphocytic chorio-
meningitis virus. J. Immunol. 161:3215–3218.
39. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and
CD8 expression by dendritic cell subtypes in mouse thymus and spleen.
J. Immunol. 164:2978–2986.
40. Wang, X. Z., M. A. Brehm, and R. M. Welsh. 2004. Preapoptotic phenotype
of viral epitope-specific CD8 T cells precludes memory development and is
an intrinsic property of the epitope. J. Immunol. 173:5138–5147.
41. Wang, X. Z., S. E. Stepp, M. A. Brehm, H. D. Chen, L. K. Selin, and R. M.
Welsh. 2003. Virus-specific CD8 T cells in peripheral tissues are more resis-
tant to apoptosis than those in lymphoid organs. Immunity 18:631–642.
42. Welsh, R. M., Jr., P. W. Lampert, P. A. Burner, and M. B. Oldstone. 1976.
Antibody-complement interactions with purified lymphocytic choriomenin-
gitis virus. Virology 73:59–71.
4876 BAHL ET AL. J. VIROL.
 o
n
 June 1, 2016 by UNIV O
F M
ASS M
ED SCH
http://jvi.asm.org/
D
ow
nloaded from
 
43. Whitton, J. L., P. J. Southern, and M. B. Oldstone. 1988. Analyses of the
cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein com-
ponents of lymphocytic choriomeningitis virus. Virology 162:321–327.
44. Wojciechowski, S., M. B. Jordan, Y. Zhu, J. White, A. J. Zajac, and D. A.
Hildeman. 2006. Bim mediates apoptosis of CD127(lo) effector T cells and
limits T cell memory. Eur. J. Immunol. 36:1694–1706.
45. Wong, R. S., A. Wu, K. F. To, N. Lee, C. W. Lam, C. K. Wong, P. K. Chan,
M. H. Ng, L. M. Yu, D. S. Hui, J. S. Tam, G. Cheng, and J. J. Sung. 2003.
Haematological manifestations in patients with severe acute respiratory syn-
drome: retrospective analysis. BMJ 326:1358–1362.
46. Yang, H. Y., P. L. Dundon, S. R. Nahill, and R. M. Welsh. 1989. Virus-induced
polyclonal cytotoxic T lymphocyte stimulation. J. Immunol. 142:1710–1718.
VOL. 84, 2010 EARLY T-CELL APOPTOSIS 4877
 o
n
 June 1, 2016 by UNIV O
F M
ASS M
ED SCH
http://jvi.asm.org/
D
ow
nloaded from
 
JOURNAL OF VIROLOGY, June 2010, p. 6262 Vol. 84, No. 12
0022-538X/10/$12.00 doi:10.1128/JVI.00870-10
Copyright © 2010, American Society for Microbiology. All Rights Reserved.
ERRATUM
Analysis of Apoptosis of Memory T Cells and Dendritic Cells during the Early
Stages of Viral Infection or Exposure to Toll-Like Receptor Agonists
Kapil Bahl,1 Anette Hu¨bner,3 Roger J. Davis,3 and Raymond M. Welsh2*
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 065101; Department of Pathology,
Program in Immunology and Virology, University of Massachusetts Medical School, Worcester, Massachusetts 016552;
and Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, Massachusetts 016053
Volume 84, no. 10, p. 4866–4877, 2010. Page 4866: The byline should appear as shown above.
6262
